Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

AIM: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit from treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Blaschke, Florian, Lacour, Philipp, Dang, Phi Long, Parwani, Abdul Shokor, Hohendanner, Felix, Walter, Thula, Klingel, Karin, Kühl, Uwe, Heinzel, Frank R., Sherif, Mohammad, Boldt, Leif‐Hendrik, Pieske, Burkert, Tschöpe, Carsten
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Short Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318471/
https://ncbi.nlm.nih.gov/pubmed/33932118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados